Clinical trials recruiting for Stem Cell Transplant Complications
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Alemtuzumab | 1 |
| Sirolimus | 1 |
| Total Body Irradiation | 1 |
| tabelecleucel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| New York | 1 |
| North Carolina | 1 |
| Ohio | 1 |
Top cities
Self-screener
Recruiting trials
- A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
Related conditions
Trials recruiting for Stem Cell Transplant Complications often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stem Cell Transplant Complications trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.